评估个体内对比剂强化变异性以确定CT可达到的最大一致性
本研究纳入100例在12个月内接受四次相同采集和注射参数CT扫描的患者,记录腹主动脉、门静脉主干、肝实质和皮下脂肪的强化值,评估个体内强化差异。结果显示34%患者腹主动脉、38%门静脉、33%肝实质存在临床相关变异;延迟时间变异与腹主动脉强化变异显著相关(p=0.009),女性与肝实质变异相关(p=0.008)。
要点
- 相同扫描和注射参数下,约三分之一患者腹主动脉、门静脉和肝实质强化存在临床相关变异。
- 延迟时间变异是唯一与腹主动脉强化变异相关的可控因素(p=0.009)。
- 门静脉强化变异与所有记录变量均无统计学显著关联。
核心结论
- 约三分之一患者即使使用相同扫描和注射参数,腹主动脉、门静脉和肝实质强化仍可能出现临床相关变异。
- 延迟时间是唯一与腹主动脉强化变异相关的可控因素;门静脉和肝实质强化变异无其他可控因素相关。
研究设计与样本
- 研究纳入100例在12个月内接受四次CT扫描的患者,所有扫描采集参数和对比剂注射参数相同。
- 记录腹主动脉、门静脉主干、肝实质和皮下脂肪的强化值,以及患者人口学和体型数据、注射相关因素(包括从注射对比剂到图像采集的延迟时间)。
- 对每例患者所有配对强化差异评估绝对变化和百分比变化。
关键影像表现/征象
- 基于预定阈值,腹主动脉强化临床相关变异见于34%患者,门静脉主干见于38%患者,肝实质见于33%患者。
诊断标准与关键数值
- 原文未报告敏感度、特异度、AUC、阈值或分级标准。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The purpose of this study was to quantify temporal variability in vascular and parenchymal enhancement within the same patient and to determine technique-related factors contributing to this variability. MATERIALS AND METHODS. We identified 100 patients who underwent four CT scans within 12 months with identical acquisition and contrast injection parameters. Enhancement was recorded in the abdominal aorta, main portal vein, liver parenchyma, and subcutaneous fat. Patient demographic and body habitus data were recorded. Injection-related factors were recorded including delay time from contrast injection to image acquisition. All pairwise differences in enhancement within each patient were evaluated for absolute and percentage change. RESULTS. Based on predetermined thresholds, we observed clinically relevant variability in 34% of patients for the abdominal aorta, 38% for the portal vein, and 33% for the liver parenchyma. A highly significant association was observed between higher variability in delay time and variability in the abdominal aorta (p = 0.009) and between female sex and variability in liver parenchyma (p = 0.008). A marginally significant association was seen between increasing age (p = 0.025) and female sex (p = 0.039) with variability in the abdominal aorta. No statistically significant association was found between all recorded variables and variability in the portal vein. CONCLUSION. Approximately one-third of patients may show clinically relevant variability in enhancement of the abdominal aorta, portal vein, and liver parenchyma even when using identical scanning and injection parameters. Delay time was the only controllable factor associated with variability in enhancement of the abdominal aorta; no other controllable factor is associated with variability in the portal vein or liver parenchyma.
引用
- Johnson DY, Farjat AE, Vernuccio F, et al. Evaluation of Intraindividual Contrast Enhancement Variability for Determining the Maximum Achievable Consistency in CT. AJR Am J Roentgenol. 2019. PMID: 31573858. doi:10.2214/AJR.19.21628
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。